Aakaar Medical Technologies Limited (AAKAAR)
Aakaar Medical Technologies' promoters declared no encumbrance on their equity shares for the financial year ended March 31, 2026. This annual disclosure ensures compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, providing transparency to investors.
Apr 08 2026 16:04:00
Aakaar Medical Technologies Limited (AAKAAR)
Aakaar Medical Technologies' board will meet on May 15, 2026, to consider and approve the audited standalone financial results for FY26. The trading window for insiders is closed from April 1, 2026, to May 17, 2026, ensuring compliance during the results finalization period.
Apr 01 2026 12:04:00
Aakaar Medical Technologies Limited (AAKAAR)
Aakaar Medical Technologies board will meet on May 15, 2026, to consider and approve audited financial results for FY26. The trading window will remain closed from April 1, 2026, until May 17, 2026.
Apr 01 2026 12:04:00
Read More